Why Microbot Medical thinks it can win the stroke telesurgery race

Microbot Medical received FDA 510(k) clearance in September 2025 for its Liberty robotic system, a fully disposable, single-use endovascular navigation device designed for remote delivery and manipulation of guidewires and catheters. The company is positioning Liberty as a contender in the telesurgery market, particularly for stroke intervention applications.